Pliant Therapeutics Inc (PLRX)

08:44 AM

Short Interest Drops in Pliant Therapeutics Inc. After Rally2025 Support & Resistance & Growth Focused Stock Reports - newsyoung.net

08:44 AM

12:21 PM

Is Pliant Therapeutics Inc. currently under institutional pressureJuly 2025 Sector Moves & Verified Momentum Stock Ideas - metrotimes.co.kr

12:21 PM

Aug 14, 2025

Pliant Therapeutics Reports Q2 2025 Financial Results - TipRanks

Aug 14, 2025

Aug 13, 2025

Is Pliant Therapeutics Inc. a defensive stockMarket Volume Summary & Free High Accuracy Swing Entry Alerts - thegnnews.com

Aug 13, 2025

Aug 11, 2025

Citi Maintains Pliant Therapeutics(PLRX.US) With Hold Rating, Maintains Target Price $1.7 - 富途牛牛

Aug 11, 2025

Aug 10, 2025

Citi Raises Pliant Therapeutics Price Target to $1.70 Amid Unclear Path Forward - AInvest

Aug 10, 2025

Aug 10, 2025

Healthcare Sector Analysts Weigh In on Sangamo Biosciences, Pliant Therapeutics, and Zimmer Biomet Holdings - AInvest

Aug 10, 2025

Aug 09, 2025

Citi Reaffirms Their Hold Rating on Pliant Therapeutics (PLRX) - The Globe and Mail

Aug 09, 2025

Aug 09, 2025

A Quick Look at Today's Ratings for Pliant Therapeutics(PLRX.US), With a Forecast Between $1.7 to $4 - 富途牛牛

Aug 09, 2025

Aug 08, 2025

Pliant Therapeutics Pivots To Oncology After Ending IPF Program - Finimize

Aug 08, 2025

Aug 08, 2025

Pliant Therapeutics shares fall 1.25% intraday after workforce realignment and BEACON-IPF closure. - AInvest

Aug 08, 2025

Aug 08, 2025

RBC Capital Maintains Pliant Therapeutics(PLRX.US) With Hold Rating, Maintains Target Price $3 - 富途牛牛

Aug 08, 2025

Aug 08, 2025

Pliant Therapeutics stock price target slashed by Piper Sandler - Investing.com Canada

Aug 08, 2025

Aug 08, 2025

Needham Maintains Pliant Therapeutics(PLRX.US) With Hold Rating - 富途牛牛

Aug 08, 2025

Aug 08, 2025

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - 富途牛牛

Aug 08, 2025

Aug 08, 2025

Pliant Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 08, 2025

Aug 07, 2025

Pliant Therapeutics reports Q2 EPS (71c), consensus (68c) - TipRanks

Aug 07, 2025

Aug 07, 2025

Pliant Therapeutics Q2 net loss narrows - MarketScreener

Aug 07, 2025

Aug 07, 2025

Pliant Therapeutics reports Q2 FY25 financial results, Phase 1 oncology trial on track. - AInvest

Aug 07, 2025

Aug 07, 2025

Pliant Therapeutics Discontinues Key IPF Drug Trial, Pivots Focus to Promising Oncology Program - Stock Titan

Aug 07, 2025

Aug 05, 2025

Pliant Therapeutics shares rise 2.65% intraday after IDEAYA Biosciences reports positive Phase 2/3 trial data. - AInvest

Aug 05, 2025

Aug 04, 2025

Should I hold or sell Pliant Therapeutics Inc. stock in 2025Tremendous financial leverage - Jammu Links News

Aug 04, 2025

Aug 03, 2025

Pliant Therapeutics Inc. Stock Analysis and ForecastRapidly expanding wealth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How many analysts rate Pliant Therapeutics Inc. as a “Buy”Identify undervalued stocks ready to soar - Jammu Links News

Aug 03, 2025

Aug 03, 2025

A Quick Look at Today's Ratings for Pliant Therapeutics(PLRX.US), With a Forecast Between $3 to $17 - 富途牛牛

Aug 03, 2025

Aug 03, 2025

How volatile is Pliant Therapeutics Inc. stock compared to the marketDiscover hidden gems in the stock market - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Pliant Therapeutics Inc. compare to its industry peersInvest confidently with market-leading analysis - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Pliant Therapeutics Inc. a good long term investmentInvest confidently with expert support - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Does Pliant Therapeutics Inc. stock perform well during market downturnsAchieve rapid portfolio growth with expert guidance - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the risk reward ratio of investing in Pliant Therapeutics Inc. stockGame-changing returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What makes Pliant Therapeutics Inc. stock price move sharplyFree Stock Market Return Analysis - Jammu Links News

Aug 03, 2025

Aug 02, 2025

What are Pliant Therapeutics Inc. company’s key revenue driversDiscover undervalued opportunities early - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What is Pliant Therapeutics Inc. company’s growth strategyBuild wealth steadily with smart stock selection - Jammu Links News

Aug 02, 2025

Aug 01, 2025

Pliant Therapeutics Inc. Trading Near Value Zone — Recovery AheadTop Performing Stock Insights Released Daily - metal.it

Aug 01, 2025

Jul 31, 2025

What are analysts’ price targets for Pliant Therapeutics Inc. in the next 12 monthsAdvanced Screener Planner For 2025 - Jammu Links News

Jul 31, 2025

Jul 30, 2025

Competitive Positioning of Pliant Therapeutics Inc.: Is It Leading or LaggingWeekly Return Pick Forecast Reports Show Trend - metal.it

Jul 30, 2025

Jul 29, 2025

Published on: 2025-07-30 01:15:54 - metal.it

Jul 29, 2025

Jul 29, 2025

Bollinger Bands Expand on Pliant Therapeutics Inc. — Volatility AheadWatchlist for Smart Swing Trading Updated - beatles.ru

Jul 29, 2025

Jul 29, 2025

Will Pliant Therapeutics Inc. stock split in the near futureInvestment Playbook for Growing Markets Shared - metal.it

Jul 29, 2025

Jul 29, 2025

Pliant Therapeutics Inc. Sees Spike in Bullish Option FlowDaily Momentum Screener With Alerts Launched - metal.it

Jul 29, 2025

Jul 28, 2025

What catalysts could drive Pliant Therapeutics Inc. stock higher in 2025Unprecedented profit potential - Jammu Links News

Jul 28, 2025

Jul 28, 2025

Pliant Therapeutics Inc. Added to High Probability Setup ListLow Risk High Return Opportunities Identified - metal.it

Jul 28, 2025

Jul 28, 2025

What is the dividend policy of Pliant Therapeutics Inc. stockFree Trading Psychology Coaching - Jammu Links News

Jul 28, 2025